HGFR/c-MET PE-conjugated Antibody FAB3582P from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHGFR/c-MET PE-conjugated Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $459.00Supplier Page View Company Product Page
Catalog NumberFAB3582P
NCBI Gene Aliasesc-Met, HGFR, AUTS9, DA11, RCCP2, DFNB97
ApplicationsFlow Cytometry,Western Blot
IsotypeIgG1
Clone95106
Conjugate/TagPhycoerythrin
TargetHGFR/c-MET
ReactivityHuman
Quantity100 Tests
HostMouse
NCBI Full Gene NameMET proto-oncogene, receptor tyrosine kinase
ClonalityMonoclonal
FormatSupplied in a saline solution containing BSA and Sodium Azide
ImmunogenMouse myeloma cell line NS0-derived recombinant human HGF R/c-MET, Glu25-Thr932, Accession # P08581
PurityProtein A or G purified from hybridoma culture supernatant
Antibody TypePrimary Antibodies
StorageProtect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied

Specifications/Features

Available conjugates: Available conjugates: Phycoerythrin

Specificity: Detects human HGF R/c-MET.

Sizes Available: 100 Tests

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) [18F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinomaMolecular CancerMarch 29, 2026Stefan Stoiber, Daniel Pölöske, Clemens P. Spielvogel, Elisabeth Gurnhofer, Michaela Schlederer, David Haberl, Cécile Philippe, Dominik P. Elmer, Richard Morrigl, Heidi A. Neubauer, et al.#311,118, RRID:AB_2072735), FITC-CD44 (BioLegend, #338,804, RRID:AB_1501197) and PE-c-MET (R&D Systems, FAB3582P, RRID:AB_1026293). After staining, cells were washed twice in MACS buffer and resuspended in 100 µL

(2) Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomasCell reportsAugust 29, 2023De Bacco F, Orzan F, Crisafulli G, Prelli M, Isella C, Casanova E, Albano R, Reato G, Erriquez J, D'Ambrosio A, et al.

(3) Endosomal LC3C-pathway selectively targets plasma membrane cargo for autophagic degradationNature communicationsJuly 2, 2022Coelho PP, Hesketh GG, Pedersen A, Kuzmin E, Fortier AN, Bell ES, Ratcliffe CDH, Gingras AC, Park M.pathway. For staining the following fluorescent-labeled antibodies were used: PE anti-MET (clone 95106; #FAB3582P R&D systems), APC anti-CD71 (clone CY1G4; #334108 Biolegend), PE mouse IgG1 κ isotype control (clone

(4) HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical FindingsInternational journal of molecular sciencesNovember 20, 2020Boschert V, Teusch J, Aljasem A, Schmucker P, Klenk N, Straub A, Bittrich M, Seher A, Linz C, Müller-Richter UDA, et al.ThermoFisher Scientific (Waltham, MA, USA), β-Actin antibody (A5316) from Merck, and PE conjugated Met antibody (FAB3582P) from R&D Systems (Minneapolis, MN, USA). All antibodies were applied as stated in the instructions

(5) Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapyScience advancesMay 1, 2020Wang SJ, Li R, Ng TSC, Luthria G, Oudin MJ, Prytyskach M, Kohler RH, Weissleder R, Lauffenburger DA, Miller MA.

(6) Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cellsBMC cancerMay 24, 2019Jo EB, Lee YS, Lee H, Park JB, Park H, Choi YL, Hong D, Kim SJ.

(7) Ezrin Promotes Stem Cell Properties in Pancreatic Ductal AdenocarcinomaMolecular cancer research : MCRApril 1, 2019Penchev VR, Chang YT, Begum A, Ewachiw T, Gocke C, Li J, McMillan RH, Wang Q, Anders R, Marchionni L, et al.

(8) Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesionOncogeneApril 7, 2016Tervonen TA, Belitškin D, Pant SM, Englund JI, Marques E, Ala-Hongisto H, Nevalaita L, Sihto H, Heikkilä P, Leidenius M, et al.

(9) Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific AntibodyThe Journal of biological chemistryOctober 9, 2015Jarantow SW, Bushey BS, Pardinas JR, Boakye K, Lacy ER, Sanders R, Sepulveda MA, Moores SL, Chiu ML.

(10) Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug developmentPloS oneJanuary 1, 2014Ekert JE, Johnson K, Strake B, Pardinas J, Jarantow S, Perkinson R, Colter DC.

(11) Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-RPloS oneJanuary 1, 2014Mirkina I, Hadzijusufovic E, Krepler C, Mikula M, Mechtcheriakova D, Strommer S, Stella A, Jensen-Jarolim E, Höller C, Wacheck V, et al.

(12) An essential receptor for adeno-associated virus infectionNatureJanuary 1, 0001"Pillay S, Meyer NL, Puschnik AS, Davulcu O, Diep J, Ishikawa Y, Jae LT, Wosen JE, Nagamine CM, Chapman MS, et al."

Be the First to Write a Review!

HGFR/c-MET PE-conjugated Antibody

HGFR/c-MET PE-conjugated Antibody

HGFR/c-MET PE-conjugated Antibody

HGFR/c-MET PE-conjugated Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (12)

Reviews

HGFR/c-MET PE-conjugated Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map